Bone Void Fillers Market Report 2026

Bone Void Fillers Market Overview

• Bone Void Fillers market size has reached to $3.78 billion in 2025 • Expected to grow to $5.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Growing Burden Of Bone Diseases Fueling Growth In The Bone Void Fillers Market • Market Trend: Advancements In Bone Healing Through Carbohydrate Polymer Technologies • North America was the largest region in 2025.

What Is Covered Under Bone Void Fillers Market?

Bone void fillers are materials used to fill defects or discontinuities in bone tissue, often resulting from pathologic processes such as trauma, degenerative, or neoplastic conditions. These fillers can be synthetic or natural, and they provide an osteoconductive matrix to facilitate bone healing. The main types of bone void fillers are demineralized bone matrix, calcium phosphate bone graft substitute, collagen matrix, and others. Calcium-phosphate bone graft substitutes are usually either tricalcium phosphate or hydroxyapatite, which is the primary mineral in bone. The various types of forms include gel and putty, granules, and others. These are used in various applications such as bone fracture, spine fusion, others and also by various end-users such as hospitals, and specialty clinics.

What Is The Bone Void Fillers Market Growth Forecast?

The bone void fillers market size is expected to see strong growth in the next few years. It will grow to $5.18 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive bone repair solutions, expansion of sports injury treatments, growing adoption of bioactive graft materials, increasing focus on regenerative medicine. Major trends in the forecast period include increasing adoption of synthetic bone graft substitutes, rising use of injectable bone void fillers, growing preference for osteoconductive biomaterials, expansion of minimally invasive orthopedic procedures, enhanced focus on faster bone regeneration.

Global Bone Void Fillers Market Segmentation

1) By Type: Demineralized Bone Matrix, Calcium phosphate Bone Graft Substitute, Collagen Matrix, Other Types 2) By Form: Gel And Putty, Granules, Other Forms 3) By Application: Bone Fracture, Spine Fusion, Other Applications 4) By End-User: Hospital, Specialty Clinics Subsegments: 1) By Demineralized Bone Matrix: Freeze-Dried Demineralized Bone Matrix (FDBM), Demineralized Bone Matrix Putty 2) By Calcium Phosphate Bone Graft Substitute: Hydroxyapatite, Tricalcium Phosphate 3) By Collagen Matrix: Collagen-Based Gel, Collagen-Based Sponge 4) By Other Types: Synthetic Bone Graft Substitutes, Bone Morphogenetic Proteins (BMPs)

What Is The Driver Of The Bone Void Fillers Market?

The growing burden of bone diseases is expected to propel the growth of the bone void filler market going forward. Bone diseases are medical conditions that affect the structure and function of the bones, leading to abnormalities such as weakness, deformity, pain, and impaired growth or repair. Bone void fillers are useful for treating bone diseases by promoting bone growth and repair in areas where bone is damaged by promoting quicker healing, reducing pain, and enhancing the overall success of bone-related treatments. For instance, in August 2023, according to the Institute for Health Metrics and Evaluation (IHME), a US-based research institution, projections indicate that almost 1 billion individuals are expected to suffer from osteoarthritis, with knee osteoarthritis expected to rise by 75% and hand osteoarthritis by 50% by 2050. Therefore, the growing burden of bone diseases is driving the growth of the bone void filler industry.

Key Players In The Global Bone Void Fillers Market

Major companies operating in the bone void fillers market are Johnson & Johnson, Medtronic plc, Heraeus Group, Stryker Corporation, Huntsman Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew plc, Arthrex Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., Biocomposites Ltd., Aziyo Biologics Inc., Bone Support AB, Collagen Matrix Inc., Royal Biologics Inc., FlexForm Technologies, Orthorebirth Co. Ltd, Vivex Biologics, Mitsubishi Tanabe Pharma Corporation, OsteoBiologics Inc., Bacterin International Inc.

Global Bone Void Fillers Market Trends and Insights

Major companies operating in the bone void fillers market are focused on developing innovative products, such as carbohydrate polymer bone graft substitutes, to increase their profitability in the market. A carbohydrate polymer bone graft substitute used as a bone void filler is a synthetic material engineered to mimic the structure of natural bone, promoting the body's bone healing and regeneration processes in areas where bone loss has occurred. For instance, in May 2023, Royal Biologics, a US-based orthobiologics and life science company, launched Bio-Reign 3D, a bone graft substitute made from a hyper-crosslinked natural carbohydrate polymer. It offers an optimal environment for cell growth and blood vessel formation, aiding in bone regeneration. This innovative material transitions from radiolucent to radiopaque as healing progresses, allowing for monitoring of the healing process. It also boasts superior compression, tensile strength, and ease of use, ensuring effective shaping and application of the graft.

What Are Latest Mergers And Acquisitions In The Bone Void Fillers Market?

In April 2023, Henry Schein Inc., a US-based healthcare company, acquired a majority ownership stake in Biotech Dental SAS for an undisclosed amount. Through this acquisition, Henry Schein aims to enhance digital integration between Biotech Dental's innovative software and its product suite, fostering streamlined workflows and improved patient outcomes while driving global expansion in the implant and orthodontics sectors. Biotech Dental is a France-based provider of bone void fillers.

Regional Outlook

North America was the largest region in the bone void fillers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bone Void Fillers Market?

The bone void filler market consists of sales of demineralized bone matrix, bioactive glass, bone morphogenetic proteins, and human bone (autografts and allografts). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.